Cargando…

The BET Inhibitor GS-5829 Targets Chronic Lymphocytic Leukemia Cells and Their Supportive Microenvironment

Despite major improvements in treatment outcome with novel targeted therapies, such as the Bruton tyrosine kinase (BTK) inhibitor ibrutinib, chronic lymphocytic leukemia (CLL) remains incurable in the majority of patients. Activation of PI3K, NF-κB, and/or MYC has been linked to residual disease and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ekaterina, ten Hacken, Elisa, Sivina, Mariela, Clarke, Astrid, Thompson, Philip A., Jain, Nitin, Ferrajoli, Alessandra, Estrov, Zeev, Keating, Michael J., Wierda, William G., Bhalla, Kapil N., Burger, Jan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272263/ https://www.ncbi.nlm.nih.gov/pubmed/31862959 http://dx.doi.org/10.1038/s41375-019-0682-7

Ejemplares similares

Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Aggarwal, Rahul, et al.
Publicado: (2022)

P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL
por: Burger, Jan, et al.
Publicado: (2023)

The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells
por: Fiorcari, Stefania, et al.
Publicado: (2013)

STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
por: Rozovski, Uri, et al.
Publicado: (2018)

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells
por: Rozovski, Uri, et al.
Publicado: (2018)

PB1883: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINOTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS INDUCES DEEP REMISSIONS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL.
por: Burger, J., et al.
Publicado: (2022)

How Academics Face the World: A Study of 5829 Homepage Pictures
por: Churches, Owen, et al.
Publicado: (2012)

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells
por: Rozovski, Uri, et al.
Publicado: (2021)

Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumab
por: Jain, Punit, et al.
Publicado: (2016)

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies
por: Thompson, Philip A., et al.
Publicado: (2018)

BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
por: Fiskus, Warren, et al.
Publicado: (2021)

Ruxolitinib for symptom control in patients with Chronic Lymphocytic leukemia: A Phase II Trial
por: Jain, Preetesh, et al.
Publicado: (2017)

Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells
por: Rozovski, Uri, et al.
Publicado: (2013)

The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action
por: Chen, Rong, et al.
Publicado: (2021)

A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL
por: Jain, Nitin, et al.
Publicado: (2016)

Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells
por: Li, Ping, et al.
Publicado: (2010)

The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide
por: Shaim, Hila, et al.
Publicado: (2018)

Elimination of Chronic Lymphocytic Leukemia Cells in Stromal Microenvironment by Targeting CPT with an Anti-Angina Drug Perhexiline
por: Liu, Pan-pan, et al.
Publicado: (2016)

Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry
por: Luk, Andrea O.Y., et al.
Publicado: (2008)

To Bet or Not to Bet on T-bet As a Therapeutic Target in Emphysema?
por: Wang, Xiaoyun, et al.
Publicado: (2019)

Behind the scenes of GS: preventing and curing - the GS-SE group
por: CERN, GS-SE
Publicado: (2013)

HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist
por: Devaraj, Santhana G. T., et al.
Publicado: (2015)

Signal Transducer and Activator of Transcription–3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia
por: Li, Ping, et al.
Publicado: (2013)

Regulation of Mcl-1 Expression in Context to Bone Marrow Stromal Microenvironment in Chronic Lymphocytic Leukemia()
por: Balakrishnan, Kumudha, et al.
Publicado: (2014)

GS BBQ 2015
por: Rueda, Laura
Publicado: (2015)

Lifetime Prediction of Polymers: To Bet, or Not to Bet—Is This the Question?
por: Blanco, Ignazio
Publicado: (2018)

Pion photoproduction and the "anomalous" transition $^{14}$N$_{g.s.}$ --> $^{14}$C$_{g.s.}$
por: Figureau, A, et al.
Publicado: (1980)

Behind the scenes of GS: preventing and curing - the GS-SE group (VERSION FR)
por: CERN, GS-SE
Publicado: (2013)

A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis
por: Jain, Preetesh, et al.
Publicado: (2017)

The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells()()
por: Vangapandu, Hima V., et al.
Publicado: (2017)

The 5Gs of family business
por: Vieira, Walter, et al.
Publicado: (2018)

CpGs relieve arthritis
por: Bashyam, Hema
Publicado: (2007)

Learning Not to Bet
por: Seager, Philip
Publicado: (1969)

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
por: Amirian, E. Susan, et al.
Publicado: (2020)

BET inhibitors: Betting on improved outcomes in uterine serous carcinoma
por: Zeybek, Burak, et al.
Publicado: (2018)

Bet‐hedging and best‐bet strategies shape seed dormancy
por: Pausas, Juli G., et al.
Publicado: (2022)

Determinants of problem sports betting among college students: moderating roles of betting frequency and impulsive betting tendency
por: Shen, Yawen
Publicado: (2023)

P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)
por: Kadia, T., et al.
Publicado: (2022)

Novel BET protein Proteolysis Targeting Chimera (BET-PROTAC) exerts superior lethal activity than Bromodomain Inhibitor (BETi) against post-myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells
por: Saenz, Dyana T., et al.
Publicado: (2017)

FlaGs and webFlaGs: discovering novel biology through the analysis of gene neighbourhood conservation
por: Saha, Chayan Kumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vpuv2uioa60g2o3kh7abdusean